A detailed history of Moors & Cabot, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Moors & Cabot, Inc. holds 433,719 shares of PFE stock, worth $11.3 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
433,719
Previous 451,182 3.87%
Holding current value
$11.3 Million
Previous $12.6 Million 0.58%
% of portfolio
0.64%
Previous 0.68%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$27.7 - $31.39 $483,725 - $548,163
-17,463 Reduced 3.87%
433,719 $12.6 Million
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $1.8 Million - $2.1 Million
71,082 Added 18.7%
451,182 $12.6 Million
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $3.59 Million - $4.12 Million
138,492 Added 57.32%
380,100 $10.5 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $285,653 - $371,032
-10,932 Reduced 4.33%
241,608 $6.96 Million
Q3 2023

Nov 07, 2023

SELL
$32.09 - $37.51 $2.7 Million - $3.16 Million
-84,147 Reduced 24.99%
252,540 $8.38 Million
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $200,538 - $232,018
-5,552 Reduced 1.62%
336,687 $12.3 Million
Q1 2023

May 04, 2023

BUY
$39.39 - $51.28 $49,592 - $64,561
1,259 Added 0.37%
342,239 $14 Million
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $291,206 - $380,137
-6,975 Reduced 2.0%
340,980 $17.5 Million
Q4 2022

Feb 06, 2023

BUY
$41.75 - $54.5 $264,152 - $344,821
6,327 Added 1.85%
347,955 $17.8 Million
Q3 2022

Nov 07, 2022

SELL
$43.76 - $53.42 $224,051 - $273,510
-5,120 Reduced 1.48%
341,628 $15 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $34,339 - $40,715
-738 Reduced 0.21%
346,748 $18.2 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $813,343 - $1.01 Million
-17,778 Reduced 4.87%
347,486 $18 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $15.1 Million - $22.4 Million
-365,932 Reduced 50.05%
365,264 $21.6 Million
Q3 2021

Dec 08, 2021

BUY
$39.25 - $50.42 $27.5 Million - $35.3 Million
700,196 Added 2258.7%
731,196 $31.5 Million
Q3 2021

Nov 05, 2021

SELL
$39.25 - $50.42 $12.8 Million - $16.4 Million
-325,023 Reduced 91.29%
31,000 $31,000
Q2 2021

Aug 10, 2021

BUY
$35.91 - $40.68 $213,449 - $241,801
5,944 Added 1.7%
356,023 $13.9 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $691,468 - $779,837
20,647 Added 6.27%
350,079 $12.7 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $298,184 - $379,167
8,909 Added 2.78%
329,432 $12.1 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $1.82 Million - $2.13 Million
57,179 Added 21.71%
320,523 $11.8 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $1.95 Million - $2.36 Million
64,712 Added 32.58%
263,344 $8.61 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $737,729 - $1.05 Million
-27,293 Reduced 12.08%
198,632 $6.48 Million
Q4 2019

Jan 28, 2020

BUY
$32.92 - $37.36 $20,542 - $23,312
624 Added 0.28%
225,925 $8.89 Million
Q3 2019

Oct 22, 2019

BUY
$32.49 - $42.13 $505,836 - $655,921
15,569 Added 7.42%
225,301 $8.1 Million
Q2 2019

Jul 18, 2019

BUY
$36.98 - $41.52 $592,974 - $665,773
16,035 Added 8.28%
209,732 $9.09 Million
Q1 2019

May 06, 2019

SELL
$37.5 - $41.2 $7.26 Million - $7.98 Million
-193,697 Reduced 50.0%
193,697 $8.21 Million
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $7.17 Million - $7.88 Million
191,193 Added 97.45%
387,394 $16.4 Million
Q4 2018

Feb 13, 2019

SELL
$38.47 - $43.86 $724,890 - $826,453
-18,843 Reduced 8.76%
196,201 $8.58 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $142,119 - $172,382
4,123 Added 1.95%
215,044 $9.47 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $289,300 - $308,423
-8,772 Reduced 3.99%
210,921 $7.65 Million
Q1 2018

May 18, 2018

BUY
$31.91 - $37.02 $166,665 - $193,355
5,223 Added 2.44%
219,693 $7.8 Million
Q4 2017

Feb 13, 2018

BUY
$33.26 - $35.29 $570,442 - $605,258
17,151 Added 8.69%
214,470 $7.75 Million
Q3 2017

Nov 16, 2017

BUY
$31.0 - $34.15 $441,440 - $486,296
14,240 Added 7.78%
197,319 $7.05 Million
Q2 2017

Aug 15, 2017

BUY
N/A
183,079
183,079 $6.16 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.